1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Embolism, Paradoxical: new trials by email Literature Review of Embolism, Paradoxical trials Research Report on Embolism, Paradoxical
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli Apixaban, Placebo - Patent Foramen Ovale, Cardiac Implantable Electronic Device | Phase 2 | Withdrawn | Mayo Clinic | 2015-05-01 | 2018-11-16 |
Cognitive Dysfunction (1) · Foramen Ovale, Patent (1) · Stroke (1)
Brain Diseases (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Cognition Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Embolism and Thrombosis (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Heart Septal Defects (1) · Heart Septal Defects, Atrial (1) · Mental Disorders (1) · Nervous System Diseases (1)
apixaban (1)
Mayo Clinic (1)
United States (1)
Christopher DeSimone, MD (1) · Paul Friedman, MD (1) · Samuel Asirvatham, MD (1)